Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-37704 DarioHealth Corp. | (Exact name of registrant as specified in its charter) | | | --- | --- | | Delaware | 45-29 ...

DarioHealth Corp. (NASDAQ:DRIO) Q1 2023 Earnings Conference Call May 11, 2023 8:30 AM ET Company Participants Chuck Padala - Managing Director, Investor Relations Erez Raphael - Chief Executive Officer Rick Anderson - President Conference Call Participants Alex Nowak - Craig-Hallum Capital Group Charles Rhyee - Cowen Rahul Rakhit - LifeSci Capital Benjamin Haynor - Alliance Global Partners David Grossman - Stifel Financial Operator Good morning, and welcome to the DarioHealth First Quarter 2023 Results Call ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-37704 DarioHealth Corp. | (Exact name of registrant as specified in its charter) | | | | --- | --- | --- | | Delawar ...

DarioHealth Corp. (NASDAQ:DRIO) Q4 2022 Results Conference Call March 9, 2023 8:30 PM ET Company Participants Glenn Garmont - Investor Relations Erez Raphael - Chief Executive Officer Rick Anderson - President Conference Call Participants Charles Rhyee - TD Cowen Alexander Nowak - Craig-Hallum Capital Group Rahul Rakhit - LifeSci Capital Ben Haynor - Alliance Global Partners David Grossman - Stifel Operator Greetings, and welcome to the DarioHealth Fourth Quarter 2022 Results Call. At this time, all partici ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________to________________ Commission File No. 001-37704 DARIOHEALTH CORP. (Exact name of registrant as specified in its charter) Delaware 45-297316 ...

DarioHealth Corp. (NASDAQ:DRIO) Q3 2022 Results Conference Call November 15, 2022 8:30 AM ET Company Participants Glenn Garmont - IR Erez Raphael - CEO Rick Anderson - President Conference Call Participants Charles Rhyee – Cowen Rahul Rakhit - LifeSci Capital David Grossman – Stifel Ben Haynor - Alliance Global Partners Chase Knickerbocker - Craig-Hallum Operator Good day, everyone, and welcome to the DarioHealth Third Quarter 2022 Results Conference Call. [Operator Instructions] Please note, this event is ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-37704 DarioHealth Corp. | --- | --- | --- | |------------------------------------------------------------------- ...

DarioHealth Corp (NASDAQ:DRIO) Q2 2022 Earnings Conference Call August 15, 2022 8:30 AM ET Company Participants Glenn Garmont - LifeSci Advisors Erez Raphael - CEO & Director Richard Anderson - President & GM, North America Conference Call Participants Charles Rhyee - Cowen and Company Alexander Nowak - Craig-Hallum Rahul Rakhit - LifeSci Capital David Grossman - Stifel, Nicolaus & Company Benjamin Haynor - Alliance Global Partners Nathan Weinstein - Aegis Capital Corporation John Vandermosten - Zacks Small ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-37704 | --- | --- | |------------------------------------------------------------------------------------------------ ...

DarioHealth Corp. (NASDAQ:DRIO) Q1 2022 Earnings Conference Call May 12, 2022 8:30 AM ET Company Participants Glenn Garmont - Investor Relations Erez Raphael - Chief Executive Officer Rick Anderson - President & General Manager, North America Conference Call Participants Charles Rhyee - Cowen Rahul Rakhit - LifeSci Capital Nathan Weinstein - Aegis Capital John Vandermosten - Zacks David Grossman - Stifel Operator Good morning and welcome to the DarioHealth First Quarter 2022 Results Call. all participants w ...